Curaleaf Holdings (CURLF) Return on Invested Capital (2020 - 2026)
Curaleaf Holdings (CURLF) posted quarterly Return on Invested Capital of 0.0% for Q1 2026, little changed year-on-year from 0.0% in Q1 2025, and up 2.22% on a QoQ basis from 0.0% in Q4 2025.
Curaleaf Holdings (CURLF) Return on Invested Capital (2020 - 2026) Analysis & Trends
Curaleaf Holdings (CURLF) has reported Return on Invested Capital for 7 consecutive years, with 0.0% the latest figure, recorded in Q1 2026.
- Quarterly Return on Invested Capital changed 0.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
- Return on Invested Capital climbed to 0.0% in Q1 2026 per CURLF's latest filing, from 0.0% in the prior quarter.
- Over the last five years, Return on Invested Capital for CURLF reached as high as 0.0% in Q1 2026 and fell as low as 0.0% in Q3 2023.
- A 5-year average of 0.0% and a median of 0.0% in 2024 frame the typical range for Return on Invested Capital.
- Annual changes were most pronounced in 2022 — Return on Invested Capital sank 68 bps — and 2023, when it changed 0 bps.
- Year by year, Return on Invested Capital stood at 0.0% in 2022, then jumped by 61501 bps to 0.0% in 2023, then increased by 16 bps to 0.0% in 2024, then jumped by 263 bps to 0.0% in 2025, then advanced by 2 bps to 0.0% in 2026.
- According to Business Quant data, Return on Invested Capital over the past three periods registered 0.0%, 0.0%, and 0.0% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 0.01% |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 0.01% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 0.00% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 0.00% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 0.03% |
| 10 | Curaleaf Holdings | 6.95 Bn | 6.95 Bn | 157.29 Mn | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.68% |
| Sep 30, 2021 | 0.21% |
| Jun 30, 2021 | 0.16% |